Dr. Caspian Oliai
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Area of expertise
Acute Myeloid Leukemia
Caspian Oliai has run 10 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Myelogenous Leukemia
Caspian Oliai has run 9 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
UCLA / Jonsson Comprehensive Cancer Center
Ronald Regan UCLA Medical Center
Clinical Trials Caspian Oliai is currently running
Acalabrutinib Maintenance
for Large B-cell Lymphoma
This phase Ib/II trial studies the side effects and efficacy of maintenance acalabrutinib following cellular therapy in treating patients with large B-cell lymphoma at very high risk of the cancer coming back. Acalabrutinib is a small molecular inhibitor that may interfere with the ability of cancer cells to grow and spread.
Recruiting
1 award
Phase 1 & 2
24 criteria
Azacitidine/Decitabine + Venetoclax
for Acute Myeloid Leukemia
This phase II trial evaluates the effect of azacitidine or decitabine and venetoclax in treating patients with acute myeloid leukemia that has not been treated before (treatment naive) or has come back (relapsed). Chemotherapy drugs, such as azacitidine, decitabine, and venetoclax, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
More about Caspian Oliai
Clinical Trial Related
4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Caspian Oliai has experience with
- Azacitidine
- Orca-T
- Liposome-encapsulated Daunorubicin-Cytarabine
- Venetoclax
- Acalabrutinib
- Standard-of-Care
Breakdown of trials Caspian Oliai has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Caspian Oliai specialize in?
Caspian Oliai focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Caspian Oliai currently recruiting for clinical trials?
Yes, Caspian Oliai is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Caspian Oliai has studied deeply?
Yes, Caspian Oliai has studied treatments such as Azacitidine, Orca-T, Liposome-encapsulated Daunorubicin-Cytarabine.
What is the best way to schedule an appointment with Caspian Oliai?
Apply for one of the trials that Caspian Oliai is conducting.
What is the office address of Caspian Oliai?
The office of Caspian Oliai is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.